New developments in understanding focal cortical malformations

Curr Opin Neurol. 2018 Apr;31(2):151-155. doi: 10.1097/WCO.0000000000000531.

Abstract

Purpose of review: Focal cortical dysplasias (FCDs) represent common cortical malformations that are frequently associated with epilepsy. They have so far not been well understood in terms of their molecular pathogenesis, and with respect to mechanisms of seizure emergence.

Recent findings: Several recent studies have succeeded in making significant advances in understanding the molecular genetics, in particular FCD type II. A second major advance has been the development of novel rodent models of FCDs that replicate a somatic mutation seen in humans, lead to a focal lesion, and recapitulate many phenotypic features of human FCDs. We will discuss these recent advances.

Summary: These advances promise significant advances in understanding the heterogeneity of FCDs at the molecular genetic level. They also promise a much better understanding of cell-intrinsic and network mechanisms underlying increased seizure susceptibility and altered cognition. Systematic studies utilizing the approaches summarized here promise to lead to specific strategies regarding when and how to treat specific subgroups of FCDs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Brain Diseases / complications
  • Cognitive Dysfunction / complications
  • Cognitive Dysfunction / genetics
  • Cognitive Dysfunction / metabolism
  • Disease Models, Animal
  • Epilepsy / complications
  • Epilepsy / genetics*
  • Epilepsy / metabolism
  • GTPase-Activating Proteins
  • Humans
  • Malformations of Cortical Development / complications
  • Malformations of Cortical Development / genetics*
  • Malformations of Cortical Development / metabolism
  • Malformations of Cortical Development, Group I / complications
  • Malformations of Cortical Development, Group I / genetics
  • Malformations of Cortical Development, Group I / metabolism
  • Mutation
  • Phenotype
  • Phosphatidylinositol 3-Kinases / genetics
  • Repressor Proteins / genetics
  • Seizures
  • TOR Serine-Threonine Kinases / genetics
  • Tuberous Sclerosis Complex 1 Protein / genetics
  • Tuberous Sclerosis Complex 2 Protein / genetics

Substances

  • DEPDC5 protein, human
  • GTPase-Activating Proteins
  • Repressor Proteins
  • Tuberous Sclerosis Complex 1 Protein
  • Tuberous Sclerosis Complex 2 Protein
  • TOR Serine-Threonine Kinases

Supplementary concepts

  • Focal cortical dysplasia of Taylor